What is the current Asia-Pacific Self-Monitoring Blood Glucose Devices Market size?

In 2024, the Asia-Pacific Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 2.53 billion. Read More

Who are the key players in Asia-Pacific Self-Monitoring Blood Glucose Devices Market?

I-Sens, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan Inc. and Roche Diabetes Care are the major companies operating in the Asia-Pacific Self-Monitoring Blood Glucose Devices Market. Read More

What years does this Asia-Pacific Self-Monitoring Blood Glucose Devices Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Self-Monitoring Blood Glucose Devices Market size was estimated at USD 2.39 billion. The report covers the Asia-Pacific Self-Monitoring Blood Glucose Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Self-Monitoring Blood Glucose Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Self-Monitoring Blood Glucose Devices Companies

Q: How big is the Asia-Pacific Self-Monitoring Blood Glucose Devices Market?

The Asia-Pacific Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 2.53 billion in 2024 and grow at a CAGR of 5.5% to reach USD 3.30 billion by 2029. Read More

This report lists the top Asia-Pacific Self-Monitoring Blood Glucose Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia-Pacific Self-Monitoring Blood Glucose Devices industry.